22 May 2020
Visiongain has launched a new report Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis.
The automation in biopharma market is projected to grow at a CAGR of 4.3% in the first half of the forecast period. In 2019, the automation market in biopharmaceutical industry in clinical stage accounted for 62.1% of the automation in biopharmaceutical market. Visiongain estimated that ERP automation in biopharma will be the driver for market growth in the first half of the forecast period.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
• Automation in biopharma market forecasts from 2020-2030
• This report assesses the application of automation in the biopharma market and gives revenue to 2030
• Provides qualitative analysis and forecast of the submarket by technology for the period 2020-2030:
• Automation Technology
• Digitization Technology
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing
• Profiles leading companies that will be important in the development of the automation in biopharma market. For each company, developments and outlooks are discussed and companies covered in this chapter include:
• Thermo Fisher Scientific
• Zenith (Cognizant)
• RheoSense, Inc.
• Provides qualitative analysis of trends and developments that will affect the automation in biopharma market, from the perspective of biopharmaceutical companies, during the period 2020 to 2030.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.
16 September 2020
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.
14 September 2020
The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.
09 September 2020
The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.